IV amisulpride is safe & effective for managing post-op nausea & vomiting (PONV) in non-neurological setting but would it be equally effective for PONV management in patients undergoing neurosurgery? The study explores it all.
This presentation summarizes the key findings based on pulmonologists’ perspectives from a survey conducted to understand clinicians perspectives and practice patterns in both the diagnosis and treatment of group 1 and group 3 PH, which can further help optimize the management of PH patients.